Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

 

Common but Complex irAEs
17:03

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Dermatologic Side Effects of Cancer Treatment: Cutaneous Reactions Are a Significant Side Effect of Immunotherapy

FEATURING Joshua Arbesman
  • 171 views
  • March 24, 2020
  • 2
22:57

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Endocrine Complications of IO: Pituitary Hormone Profile Should Be Appropriately Monitored for Pts on Anti-CTLA-4, Primary Thyroid Dysfunction Is More Frequently Observed in Anti-PD-1/PDL-1 Therapy

FEATURING Christian Nasr
  • 172 views
  • March 24, 2020
  • 3
15:32

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Ophthalmic Side Effects and Local Therapy: Local Control of Uveitis Side Effects Is Possible, in Many Cases Without Cessation Of ICI/Targeted Therapy

FEATURING Arthi Venkat
  • 6 views
  • March 24, 2020
10:08

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Patient With Stage III Lung Adenocarcinoma Treated With Adjuvant Durvalumab: Managing Dermatologic Side Effects

FEATURING Joshua Arbesman, Arthi Venkat, Jung-Min Song, Christian Nasr
  • 82 views
  • March 24, 2020
13:44

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

59 y/o Male With Endocrine Complications: Fatigue and Weight Loss While on Nivolumab and Ipilimumab

FEATURING Joshua Arbesman, Arthi Venkat, Jung-Min Song, Christian Nasr
  • 11 views
  • March 24, 2020
06:37

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

49 y/o Female & 49 y/o Male With Ophthalmic Complications: More Serious Conditions Can Mimic Side Effects, It's Important to Do Neuro-Imaging for Optic Nerve Edema

FEATURING Joshua Arbesman, Arthi Venkat, Jung-Min Song, Christian Nasr
  • 7 views
  • March 24, 2020